Delivery Order SPE2DB20D3103-SPE2DB26FL4N0
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a competitive delivery order by the Defense Logistics Agency valued at $15,067.36 for the supply of Sprycel 100 mg tablets in quantities of 30. The contract is classified as firm fixed price and carries an ultimate completion date of August 12, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order valued at $5,322.66 by the Defense Logistics Agency Troop Support Medical to provide 30 tablets of the 100mg dosage of the cancer drug Sprycel. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is August 7-8, 2023. No subcontractors or set aside designations were indicated. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $22,304.15 to AmerisourceBergen Drug Corp for the supply of Sprycel 100 mg tablets (30-count units) on September 26, 2025, with a completion date of September 29, 2025. This firm fixed-price, competitively awarded contract carries no set-aside designation and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be delivered to the...
- The Defense Logistics Agency (DLA) awarded a $20,439.87 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Sprycel 100 mg tablets (30-count units) on July 30, 2025, with an ultimate completion date of July 31, 2025. This is a non-set-aside competitive award, reflecting AmerisourceBergen's demonstrated capability to meet federal pharmaceutical procurement requirements. The contract is a child delivery order under the company's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $16,591.33 delivery order to AmerisourceBergen Drug Corp for the supply of Sprycel 100 mg tablets (30-count units) under a firm fixed-price contract. The award was made on July 22, 2025, with an ultimate completion date of July 23, 2025, and represents a non-competitive set-aside delivery against AmerisourceBergen's existing pharmaceutical supply contract vehicle. Performance will be executed from the company's corporate office location in Conshohocken,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $45,695.78 firm fixed-price delivery order is for the supply of Sprycel 100 mg tablets, a specialty medication. The contract has an ultimate completion date of April 3, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- Amerisourcebergen Drug Corp has received a $11,343.61 firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical to supply 60 tablets of 70 mg Sprycel tablets. The order is being fulfilled under an indefinite delivery contract held by Amerisourcebergen with no set-aside designation applied. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with completion by December 19, 2023. This supports the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The award is a Firm Fixed Price delivery order for the pharmaceutical product Sprycel 140 mg tablets, with a ceiling value of $12,028.56 and a performance period through April 1, 2024. The contract does not have any set-aside designation. Amerisourcebergen Drug Corp, through its Corporate Office division, serves as a...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $16,158.06 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical (DLA) to supply 60 tablets of 70mg SPRYCEL, an oncology drug, for performance in Conshohocken, Pennsylvania from August 10-11, 2023. As the prime contractor for this contract action placed under the DLA's indefinite-delivery/indefinite-quantity pharmaceuticals distribution program, Amerisourcebergen...
- This federal contract award is for the delivery of pharmaceutical products, primarily the drug Sprycel 100 mg tablet, to support the medical needs of the U.S. government. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical division. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $13,503.06. It has an ultimate completion date of...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB26FL4N0Delivery Order
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on October 30, 2025, for the supply of Sprycel 100 mg tablets (30-count units) with a ceiling value of $62,565.85 and a firm fixed price structure. This non-competitive set-aside award, with an ultimate completion date of October 31, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which is valued at $999,999,999.00 and extends through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order exemplifies AmerisourceBergen's role as a critical pharmaceutical vendor within the Defense Logistics Agency's Medical Supply Chain, fulfilling the federal government's demand for specialty medications to support military and veteran healthcare systems. Sprycel is an oncology medication used in the treatment of certain blood cancers, reflecting the company's extensive portfolio of pharmaceutical products spanning multiple therapeutic domains. As a prime vendor under the DLA's comprehensive pharmaceutical support program, AmerisourceBergen supplies brand-name and generic medications, vaccines, and specialized medical supplies to support military healthcare programs globally, serving customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $62.6k | 10/30/25 |